Sirolimus vs. paclitaxel-eluting stent to coronary intervention in dialysis patients

International Journal of Cardiology

Volumn 165, Issue 3, 2013, Pages 533-536

  Kamoi, Daisuke ^a   Ishii, Hideki ^a   Takahashi, Hiroshi ^a   Aoyama, Toru ^a   Toriyama, Takanobu ^a   Tanaka, Miho ^a   Kawamura, Yoshihiro ^a   Kawashima, Kazuhiro ^a   Yoshikawa, Daiji ^a   Amano, Tetsuya ^a   Uetani, Tadayuki ^a   Matsubara, Tatsuaki ^b   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Hemodialysis; Paclitaxel eluting stent; Percutaneous coronary intervention; Sirolimus eluting stent

Indexed keywords

PACLITAXEL; RAPAMYCIN; ANTITHROMBOCYTIC AGENT; ISOSORBIDE DINITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TREATMENT DURATION; ANGIOCARDIOGRAPHY; COMPARATIVE STUDY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; IN-STENT RESTENOSIS; MORTALITY; PACLITAXEL ELUTING STENT; QUANTITATIVE ANALYSIS; SIROLIMUS ELUTING STENT;

AGED; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RENAL DIALYSIS; SIROLIMUS; TREATMENT OUTCOME;

EID: 84877047472     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.09.078     Document Type: Article

References (29)

1. P.S. Parfrey, and R.N. Foley The clinical epidemiology of cardiac disease in chronic renal failure J Am Soc Nephrol 10 1999 1606 1615
2. A.K. Cheung, M.J. Sarnak, and G. Yan The Hemodialysis (HEMO) Study. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients Kidney Int 58 2000 353 362
3. S.S. Naidu, F. Selzer, and A. Jacobs Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention Am J Cardiol 92 2003 1160 1164
4. K. Yasuda, H. Kasuga, and T. Aoyama Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients J Am Soc Nephrol 17 2006 2322 2332
5. C. Le Feuvre, G. Dambrin, and G. Helft Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting Heart 85 2001 556 560
6. W.H. Ahmed, S.J. Shubrooks, C.M. Gibson, D.S. Baim, and J.A. Bittl Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients Am Heart J 128 1994 293 296
7. B.R. Hemmelgarn, W.A. Ghali, and H. Quan Poor long-term survival after coronary angioplasty in patients with renal insufficiency Am J Kidney Dis 37 2001 64 72
8. R.W. Asinger, T.D. Henry, C.A. Herzog, P.R. Paulsen, and R.L. Kane Clinical outcomes of PTCA in chronic renal failure: a case-control study for comorbid features and evaluation of dialysis dependence J Invasive Cardiol 13 2001 21 28
9. M.-C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
10. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
11. D.R. Holmes, M.B. Leon, and J.W. Moses Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis Circulation 109 2004 634 640
12. A. Chieffo, N. Morici, and F. Maisano Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience Circulation 113 2006 2542 2547
13. D. Yoshikawa, S. Isobe, and K. Sato Three-year prognosis of Japanese patients with ST-elevation myocardial infarction treated with sirolimus-eluting stents Coron Artery Dis 20 2009 422 427
14. T. Aoyama, H. Ishii, and T. Toriyama Sirolimus-eluting stents versus bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis Circ J 72 2008 56 60
15. G. Nakazawa, K. Tanabe, and J. Aoki Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents Catheter Cardiovasc Interv 69 2007 808 814
16. C. Patterson, S. Mapera, and H.H. Li Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling Arterioscler Thromb Vasc Biol 26 2006 1473 1480
17. T.J. Ryan, W.B. Bauman, and J.W. Kennedy Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutics Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) Circulation 88 1993 2987 3007
18. H. Ishii, Y. Kumada, and T. Toriyama Aortic valvular calcification predicts restenosis after implantation of drug-eluting stents in patients on chronic haemodialysis Nephrol Dial Transplant 24 2009 1562 1567
19. H. Ishii, T. Toriyama, and T. Aoyama Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis Circ Cardiovasc Interv 2 2009 513 518
20. T.B. Drüeke Arterial intima and media calcification: distinct entities with different pathogenesis or all the same? Clin J Am Soc Nephrol 3 2008 1583 1584
21. M. Notohamiprodjo, K. Andrassy, J. Bommer, and E. Ritz Dialysis membranes and coagulation system Blood Purif 4 1986 130 141
22. A. Viener, M. Aviram, O.S. Better, and J.G. Brook Enhanced in vitro platelet aggregation in hemodialysis patients Nephron 43 1986 139 143
23. P.A. Lemos, C.A. Arampatzis, and A. Hoye Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents Am J Cardiol 95 2005 167 172
24. P.K. Kuchulakanti, R. Torguson, and W.W. Chu Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents Am J Cardiol 97 2006 792 797
25. M. Otsuka, M. Toyofuku, and N. Watanabe Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease EuroIntervention 6 2011 753 759
26. J.M. Lasala, D.A. Cox, and D.L. Morris Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program Am J Cardiol 103 2009 1663 1671
27. J. Machecourt, N. Danchin, and J.M. Lablanche Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry J Am Coll Cardiol 50 2007 501 508
28. R. Kumar, T.T. Lee, and A. Jeremias Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients Am J Cardiol 100 2007 1187 1191
29. M.A. Turco, J.A. Ormiston, and J.J. Popma Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program J Am Coll Cardiol Interv 1 2008 699 709